← Open Payments lookup

SAFINAZ MOSTAFA: Open Payments

NPI 1386027696 · BUFORD, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$675 in 36 payments from 9 companies in 2025. Trend: 2023 $540 · 2024 $606 · 2025 $675

Food & beverage: $675
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.8$165
Otsuka America Pharmaceutical, Inc.8$149
Neurocrine BioSciences, Inc.5$107
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$103
ABBVIE INC.4$67
Axsome Therapeutics, Inc.2$30
Lundbeck LLC1$21
Janssen Pharmaceuticals, Inc1$18
Teva Pharmaceuticals USA, Inc.1$16

Products named: COBENFY, INGREZZA, CAPLYTA, REXULTI, VRAYLAR, ABILIFY ASIMTUFII, ABILIFY MAINTENA, Auvelity.

Industry payments across GA — which companies pay providers there.